Identification of photodegradation products of nilvadipine using GC-MS

Journal of Pharmaceutical and Biomedical Analysis

Volumn 24, Issue 1, 2000, Pages 71-79

  Mielcarek, Jadwiga ^a   Stobiecki, Maciej ^b   Frański, Rafał ^c  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

^c ADAM MICKIEWICZ UNIVERSITY   (Poland)

Author keywords

1.4 Dihydropyridine derivatives; Mass spectrum; Nilvadipine; Photodegradation

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; NILVADIPINE;

ARTICLE; DRUG DEGRADATION; DRUG STABILITY; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; PHOTOCHEMISTRY; PHOTODEGRADATION; PRIORITY JOURNAL;

CALCIUM CHANNEL BLOCKERS; MASS FRAGMENTOGRAPHY; NIFEDIPINE; PHOTOLYSIS; SUPPORT, NON-U.S. GOV'T;

EID: 0034578632     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(00)00375-7     Document Type: Article

References (21)

1. R.N. Brogden, D. Mc Tavish, Drugs Aging 6 (1995) 150-171.
2. X.Y. Zhang, S. Hiraki, S. Hayasaka, Ophthalmic Res. 30 (1998) 135-141.
3. G. Faust, Fortschr. Med. 20 (1993) 188-192.
4. J. Rosenthal, J. Cardiovasc. Pharmacol. 24 (1994) 92-107.
5. H. Ueno, M. Takata, S. Oh-hashi, F. Tomoda, K. Yasumoto, H. Inoue, J. Hum. Hypertens. 9 (1995) 735-739.
6. G. Faust, J. Cardiovasc. Pharmacol. 20 (1992) 56-61.
7. J.S. Grundy, R. Kherani, R.T. Foster, J. Pharm. Biomed. Anal. 12 (1994) 1529-1535.
8. N. Hayase, Y.I. Itagaki, S. Ogawa, S. Akutsu, S.I. Inagaki, Y. Abiko, J. Pharm. Sci. 83 (1994) 532-538.
9. H. de Vries, G.M.J. Beijersbergen van Henegouwen, Photochem. Photobiol. 62 (1995) 959-963.
10. H. de Vries, G.M.J. Beijersbergen van Henegouwen, J. Photochem. Photobiol. 43 (1998) 217-221.
11. M.G. Bartlett, J.C. Spell, P.S. Mathis, et al., J. Pharm. Biomed. Anal. 18 (1998) 335-345.
12. A. Michelitsch, J. Reiner, M. Schubert, W. Likussar, Pharmazie 50 (1995) 548-549.
13. G.M.J. Beijersbergen van Henegouwen, Medicinal Photochemistry: Phototoxic and Phototherapeutic Aspects of Drugs. Advances in Drug Research, vol. 29, Academic Press, New York, 1997, pp. 79-170.
14. B.R. Matthews, Drug Dev. Ind. Pharm. 25 (1999) 831-856.
15. Guideline for the photostability testing of new drug substances and products. ICH Topic Q1B. Photostability testing of new drug substances and products, Pharmeuropa 8 (1996) 112-116.
16. CRC Handbook of Organic Photochemistry, vol. II, CRC Press, Inc. Boca Raton, FL, 1989, pp. 251-269.
17. F. Barbato, L. Grumetto, P. Morrica, Il Farmaco 49 (1994) 461-466.
18. C. Jean, R. Laplanche, J. Chromatogr. 428 (1988) 61-69.
19. T. Sakamoto, Y. Ohtake, M. Itoh, S. Tabata, T. Kuriki, K. Uno, Biomed. Chromatogr. 7 (1993) 99-103.
20. J. Dankers, J. Elshout, G. Ahr, E. Brendel, C. Heiden, J. Chromatogr. B 710 (1998) 115-120.
21. R. Heinig, V. Muschalek, G. Ahr, J. Chromatogr. B 655 (1994) 286-292.